OKYO logo

OKYO Pharma Limited (OKYO)

Profile

Full Name

OKYO Pharma Limited

Ticker Symbol

OKYO

Exchange

NASDAQ

Country

United Kingdom

IPO

May 17, 2022

Indexes

Not included

Employees

3

Key Details

Price

$1.10(+2.80%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.57(+6.56% YoY)

PE ratio

-

Next earnings date

Jan 29, 2026

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Feb 18, 25 HC Wainwright & Co.
Buy
Feb 14, 25 HC Wainwright & Co.
Buy
Feb 10, 25 HC Wainwright & Co.
Buy
Oct 24, 24 HC Wainwright & Co.
Buy
Oct 16, 24 HC Wainwright & Co.
Buy
Aug 27, 24 HC Wainwright & Co.
Buy
Jul 12, 24 HC Wainwright & Co.
Buy
Jul 11, 24 HC Wainwright & Co.
Buy
Mar 22, 24 HC Wainwright & Co.
Buy
Jan 8, 24 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for OKYO Pharma Limited?
  • Does OKYO Pharma Limited pay dividends?
  • What sector is OKYO Pharma Limited in?
  • What industry is OKYO Pharma Limited in?
  • What country is OKYO Pharma Limited based in?
  • When did OKYO Pharma Limited go public?
  • Is OKYO Pharma Limited in the S&P 500?
  • Is OKYO Pharma Limited in the NASDAQ 100?
  • Is OKYO Pharma Limited in the Dow Jones?
  • When was OKYO Pharma Limited's last earnings report?
  • When does OKYO Pharma Limited report earnings?
  • Should I buy OKYO Pharma Limited stock now?

What is the ticker symbol for OKYO Pharma Limited?

The ticker symbol for OKYO Pharma Limited is NASDAQ:OKYO

Does OKYO Pharma Limited pay dividends?

No, OKYO Pharma Limited does not pay dividends

What sector is OKYO Pharma Limited in?

OKYO Pharma Limited is in the Healthcare sector

What industry is OKYO Pharma Limited in?

OKYO Pharma Limited is in the Biotechnology industry

What country is OKYO Pharma Limited based in?

OKYO Pharma Limited is headquartered in United Kingdom

When did OKYO Pharma Limited go public?

OKYO Pharma Limited's initial public offering (IPO) was on May 17, 2022

Is OKYO Pharma Limited in the S&P 500?

No, OKYO Pharma Limited is not included in the S&P 500 index

Is OKYO Pharma Limited in the NASDAQ 100?

No, OKYO Pharma Limited is not included in the NASDAQ 100 index

Is OKYO Pharma Limited in the Dow Jones?

No, OKYO Pharma Limited is not included in the Dow Jones index

When was OKYO Pharma Limited's last earnings report?

OKYO Pharma Limited's most recent earnings report was on Jan 29, 2025

When does OKYO Pharma Limited report earnings?

The next expected earnings date for OKYO Pharma Limited is Jan 29, 2026

Should I buy OKYO Pharma Limited stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page